Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D

Overview of attention for article published in Cochrane database of systematic reviews, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Twitter Facebook Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary.

Article in Journal of musculoskeletal & neuronal interactions (March 2022)

What are the effects of pharmacological interventions for postmenopausal women with osteoporosis and chronic kidney disease (CKD) stages 3 and 4?

Article in Cochrane Clinical Answers (October 2021)